Xaira Therapeutics
AI-discovered medicines for hard problems.
About Xaira Therapeutics
Stealth $1B+ Series A in 2024 — one of the largest biotech launches ever. Combines AI drug design with in-house wet-lab validation.
Pitch deck breakdown
How Xaira Therapeutics would pitch themselves.
Target customer
Hard problems — the core audience Xaira Therapeutics's product is built around.
Problem they solve
Stealth $1B+ Series A in 2024 — one of the largest biotech launches ever. Combines AI drug design with in-house wet-lab validation. The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Xaira Therapeutics differentiates on ai-discovered medicines for hard problems. Backed by ARCH Venture Partners + Foresite, $1B+ raised — the company has resources + validation to compound this thesis. Founded by Marc Tessier-Lavigne.
Go-to-market strategy
Early-stage GTM — typically product-led growth (free tier or low-friction onboarding) paired with founder-led sales for the first 100 customers. Heavy content marketing + community presence on Twitter/X, LinkedIn, and category-specific Slack groups.
Company facts
- Category
- Other
- Funding stage
- Series A
- Total raised
- $1B+
- Founded
- 2023
- Team size
- 201-500
- HQ
- Brisbane
- Country
- United States
- Website
- xaira.com
Founders of Xaira Therapeutics
- Marc Tessier-Lavigne
Investors backing Xaira Therapeutics
- ARCH Venture Partners
- Foresite
- Sequoia
Frequently asked questions
What does Xaira Therapeutics do?
Stealth $1B+ Series A in 2024 — one of the largest biotech launches ever. Combines AI drug design with in-house wet-lab validation.
Where is Xaira Therapeutics based?
Xaira Therapeutics is based in Brisbane, United States.
When was Xaira Therapeutics founded?
Xaira Therapeutics was founded in 2023.
How much has Xaira Therapeutics raised?
Xaira Therapeutics has raised $1B+ in their Series A round.
Who founded Xaira Therapeutics?
Xaira Therapeutics was founded by Marc Tessier-Lavigne.
Who has invested in Xaira Therapeutics?
Xaira Therapeutics is backed by ARCH Venture Partners, Foresite, Sequoia.